Chemical Structure : YKL-06-101
Catalog No.: PC-73098Not For Human Use, Lab Use Only.
YKL-06-101 is a bivalent small molecule that combines mTOR inhibition (IC50=6 nM) and degradation of CDK8 (CDK8/Cyclin C IC50=31 nM).
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
YKL-06-101 is a bivalent small molecule that combines mTOR inhibition (IC50=6 nM) and degradation of CDK8 (CDK8/Cyclin C IC50=31 nM).
The bivalent degrader YKL-06-101 stops proliferation of BCR-ABL1+ (Z119, BV173) and of BCR-ABL1− cells (REH) at concentrations below 1 uM.
YKL-06-101 reduces phosphorylation of S6S240/244, as indication of mTOR inhibition.
YKL-06-101 induces cell death in human leukemic cells.
M.Wt | 1099.134 | |
Formula | C58H57F3N8O11 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Ingeborg Menzl, et al. Nat Commun. 2019 Oct 18;10(1):4741.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright